# TECENTRIQ

NDC: 50242-917
Generic name: atezolizumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20160518

FDA application: BLA761034

## Active ingredients

- ATEZOLIZUMAB: 1200 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-917"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-917
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fa682c9-a312-4932-9831-f286908660ee
